Lansoprazole Delayed release Capsules bulk supplier for pharma manufacturers

Lansoprazole Delayed Release Capsules 15 mg and 30 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 15 mg and 30 mg

Reference Brands: Prevacid(US & EU)

Lansoprazole capsules are proton pump inhibitors that irreversibly block gastric acid secretion by inhibiting the H+/K+ ATPase enzyme in stomach lining cells. They effectively treat GERD, ulcers, and Zollinger-Ellison syndrome. Benefits include symptom relief, mucosal healing, reduced acid-related complications, and improved quality of life.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Lansoprazole capsules, marketed as Prevacid, are approved in the US by the FDA and in the EU via EMA for GERD, erosive esophagitis, and Zollinger-Ellison syndrome. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety profiles, manufacturing quality, and pharmacovigilance plans. The FDA reviews detailed clinical trial and manufacturing data for timely approval, while the EMA ensures compliance with regional safety and quality standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Adherence to regional regulations supports swift approval, safe medication use, and global availability, helping millions worldwide effectively manage acid-related disorders.

Lansoprazole Delayed Release Capsules — third party manufacturing & bulk supply

Lansoprazole Delayed Release Capsules 15 mg and 30 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Lansoprazole Delayed Release Capsules is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Lansoprazole Delayed Release Capsules listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Lansoprazole Delayed Release Capsules →

Back to Listing

Frequently Asked Questions

Lansoprazole Delayed release Capsules is listed as Capsules in 15 mg and 30 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Lansoprazole Delayed release Capsules is referenced against Prevacid(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.